Treatment considerations in hutchinson-gilford progeria syndrome: a case report. 2015

H Hazan-Molina, and D Aizenbud, and Aizenbud D Dror
Orthodontic and Craniofacial Department, Graduate School of Dentistry, Rambam Health Care Campus, Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

Hutchinson-Guilford progeria syndrome is an extremely rare condition classified as one of the premature ageing syndromes. This case presents a 16-year-old Israeli female patient, suffering from a variant of Hutchinson-Guilford progeria with a history of treatment with oral biphosphnates. The patient presented with typical cranial and facial features of the syndrome including delayed teeth eruption and root development probably due to insufficient jaw growth and severs retrognatic position of the maxilla and mandible. Orthodontic treatment considerations are described along with those required in light of the previous treatment by oral biphosphonates.All primary teeth were extracted in three appointments while creating as minimal trauma as possible to the surrounding tissue and alveolar bone. For now, the patient refuses to begin the orthodontic treatment course. There are no limitations to conduct any dental procedures in progeria patients, however, extreme caution must be exercised during oral surgery due to the inelasticity of tissues and dermal atrophy. Orthodontic procedure commencement should be early enough to manage the delayed development and eruption of teeth. Patients taking oral biphosphonates should be advised of this potential complication. If orthodontic treatment is considered appropriate, plans should be assessed and modified to include compromises.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008310 Malocclusion Such malposition and contact of the maxillary and mandibular teeth as to interfere with the highest efficiency during the excursive movements of the jaw that are essential for mastication. (Jablonski, Illustrated Dictionary of Dentistry, 1982) Angle's Classification,Crossbite,Tooth Crowding,Cross Bite,Angle Classification,Angles Classification,Bite, Cross,Bites, Cross,Classification, Angle's,Cross Bites,Crossbites,Crowding, Tooth,Crowdings, Tooth,Malocclusions
D009805 Odontogenesis The process of TOOTH formation. It is divided into several stages including: the dental lamina stage, the bud stage, the cap stage, and the bell stage. Odontogenesis includes the production of tooth enamel (AMELOGENESIS), dentin (DENTINOGENESIS), and dental cementum (CEMENTOGENESIS). Odontogeneses
D010347 Patient Care Planning Usually a written medical and nursing care program designed for a particular patient. Nursing Care Plans,Goals of Care,Plans, Nursing Care,Care Goal,Care Goals,Care Plan, Nursing,Care Planning, Patient,Care Plans, Nursing,Nursing Care Plan,Plan, Nursing Care,Planning, Patient Care
D011371 Progeria An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature graying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA. Hutchinson-Gilford Syndrome,Hutchinson Gilford Progeria Syndrome,Hutchinson-Gilford Progeria Syndrome,Hutchinson Gilford Syndrome,Hutchinson-Gilford Progeria Syndromes,Progeria Syndrome, Hutchinson-Gilford,Progeria Syndromes, Hutchinson-Gilford
D002508 Cephalometry The measurement of the dimensions of the HEAD. Craniometry
D004164 Diphosphonates Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. Bisphosphonate,Bisphosphonates
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077211 Zoledronic Acid An imidobisphosphonate inhibitor of BONE RESORPTION that is used for the treatment of malignancy-related HYPERCALCEMIA; OSTEITIS DEFORMANS; and OSTEOPOROSIS. 2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid,CGP 42'446,CGP 42446A,CGP-42'446,CGP-42446,Zoledronate,Zoledronic Acid Anhydrous,Zometa,CGP 42446,CGP42'446,CGP42446

Related Publications

H Hazan-Molina, and D Aizenbud, and Aizenbud D Dror
February 2010, Minerva anestesiologica,
H Hazan-Molina, and D Aizenbud, and Aizenbud D Dror
October 2014, Indian dermatology online journal,
H Hazan-Molina, and D Aizenbud, and Aizenbud D Dror
May 1999, The Journal of dermatology,
H Hazan-Molina, and D Aizenbud, and Aizenbud D Dror
November 2004, Clinical genetics,
H Hazan-Molina, and D Aizenbud, and Aizenbud D Dror
May 2008, The New England journal of medicine,
H Hazan-Molina, and D Aizenbud, and Aizenbud D Dror
May 2008, The New England journal of medicine,
H Hazan-Molina, and D Aizenbud, and Aizenbud D Dror
May 1968, The American journal of roentgenology, radium therapy, and nuclear medicine,
H Hazan-Molina, and D Aizenbud, and Aizenbud D Dror
January 2015, Indian dermatology online journal,
H Hazan-Molina, and D Aizenbud, and Aizenbud D Dror
July 1978, Southern medical journal,
H Hazan-Molina, and D Aizenbud, and Aizenbud D Dror
January 1999, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Copied contents to your clipboard!